Stephen Krieger

2.2k total citations
79 papers, 1.2k citations indexed

About

Stephen Krieger is a scholar working on Pathology and Forensic Medicine, Neurology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Stephen Krieger has authored 79 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Pathology and Forensic Medicine, 14 papers in Neurology and 10 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Stephen Krieger's work include Multiple Sclerosis Research Studies (50 papers), Peripheral Neuropathies and Disorders (8 papers) and Rheumatoid Arthritis Research and Therapies (7 papers). Stephen Krieger is often cited by papers focused on Multiple Sclerosis Research Studies (50 papers), Peripheral Neuropathies and Disorders (8 papers) and Rheumatoid Arthritis Research and Therapies (7 papers). Stephen Krieger collaborates with scholars based in United States, Italy and Germany. Stephen Krieger's co-authors include Aaron Miller, Ilana Katz Sand, Colleen Farrell, Fred Lublin, Ezequiel Morsella, James Sumowski, Rachel Brandstadter, Michelle Fabian, Claire Riley and Sylvia Klineova and has published in prestigious journals such as PLoS ONE, Brain and Neurology.

In The Last Decade

Stephen Krieger

75 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stephen Krieger United States 20 844 286 176 168 114 79 1.2k
Rosaria Sacco Switzerland 19 1.0k 1.2× 358 1.3× 146 0.8× 223 1.3× 157 1.4× 45 1.5k
Laura De Giglio Italy 22 920 1.1× 261 0.9× 158 0.9× 98 0.6× 166 1.5× 56 1.3k
Giovanna Borriello Italy 18 886 1.0× 391 1.4× 159 0.9× 86 0.5× 120 1.1× 52 1.1k
Aurélie Ruet France 22 1.2k 1.4× 430 1.5× 188 1.1× 153 0.9× 95 0.8× 64 1.5k
Alessandro d’Ambrosio Italy 19 669 0.8× 298 1.0× 74 0.4× 225 1.3× 129 1.1× 48 1.2k
María José Sá Portugal 19 985 1.2× 297 1.0× 162 0.9× 48 0.3× 134 1.2× 99 1.4k
Rosa Gemma Viterbo Italy 19 981 1.2× 274 1.0× 109 0.6× 58 0.3× 147 1.3× 33 1.3k
María Jesús Arévalo Spain 15 1.1k 1.2× 384 1.3× 266 1.5× 96 0.6× 59 0.5× 20 1.2k
Joseph Guarnaccia United States 12 352 0.4× 301 1.1× 127 0.7× 203 1.2× 86 0.8× 17 1.1k
Marta Radaelli Italy 25 1.1k 1.3× 482 1.7× 223 1.3× 120 0.7× 111 1.0× 61 1.6k

Countries citing papers authored by Stephen Krieger

Since Specialization
Citations

This map shows the geographic impact of Stephen Krieger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen Krieger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen Krieger more than expected).

Fields of papers citing papers by Stephen Krieger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen Krieger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen Krieger. The network helps show where Stephen Krieger may publish in the future.

Co-authorship network of co-authors of Stephen Krieger

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen Krieger. A scholar is included among the top collaborators of Stephen Krieger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen Krieger. Stephen Krieger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Krieger, Stephen, Marijean Buhse, Diana M. Sima, et al.. (2024). Evaluating the effect of dimethyl fumarate on subclinical biomarkers in a real-world patient cohort. Journal of Neuroimmunology. 393. 578397–578397. 1 indexed citations
3.
Cutter, Gary, et al.. (2023). The impact of relapse definition and measures of durability on MS clinical trial outcomes. Multiple Sclerosis Journal. 29(4-5). 568–575. 7 indexed citations
4.
Sanky, Charles, et al.. (2023). Education Research: The Inappropriate Consult. PubMed. 2(1). e200044–e200044. 3 indexed citations
5.
Hua, Le H., Ahmed Z. Obeidat, Lilyana Amezcua, et al.. (2021). Consensus Curriculum for Fellowship Training in Multiple Sclerosis and Neuroimmunology. Neurology Clinical Practice. 11(4). 352–357. 2 indexed citations
6.
Petracca, Maria, Gary Cutter, Sirio Cocozza, et al.. (2021). Cerebellar pathology and disability worsening in relapsing‐remitting multiple sclerosis: A retrospective analysis from the CombiRx trial. European Journal of Neurology. 29(2). 515–521. 4 indexed citations
7.
Zhang, Yinan, et al.. (2021). Perceptions of risk and adherence to care in MS patients during the COVID-19 pandemic: A cross-sectional study. Multiple Sclerosis and Related Disorders. 50. 102856–102856. 11 indexed citations
8.
Brandstadter, Rachel, Stephen Krieger, Noam Y. Harel, et al.. (2020). Detection of subtle gait disturbance and future fall risk in early multiple sclerosis. Neurology. 94(13). e1395–e1406. 35 indexed citations
9.
Sanky, Charles, et al.. (2019). Medicolegal Considerations Influence Neurology Residents’ Perception of Inappropriate Consults (P2.9-023). Neurology. 92(15_supplement). 2 indexed citations
10.
Solomon, Andrew, et al.. (2019). Challenges in Multiple Sclerosis Diagnosis: Misapplication and Misunderstanding of the McDonald Criteria (S6.001). Neurology. 92(15_supplement). 1 indexed citations
11.
Giovannoni, Gavin, Frederik Barkhof, Hans‐Peter Hartung, et al.. (2018). ARPEGGIO: a placebo-controlled trial of oral laquinimod in primary progressive multiple sclerosis (S8.003). Neurology. 90(15_supplement). 6 indexed citations
12.
Lublin, Fred, Stacey S. Cofield, Gary Cutter, et al.. (2017). Long-term follow-up of a randomized study of combination interferon and glatiramer acetate in multiple sclerosis: Efficacy and safety results up to 7 years. Multiple Sclerosis and Related Disorders. 18. 95–102. 15 indexed citations
13.
Krieger, Stephen & James Sumowski. (2017). New Insights into Multiple Sclerosis Clinical Course from the Topographical Model and Functional Reserve. Neurologic Clinics. 36(1). 13–25. 19 indexed citations
14.
15.
Krieger, Stephen, B. Singer, Mark S. Freedman, et al.. (2016). Treatment-Naive Patients with Highly Active RRMS Demonstrated Durable Efficacy with Alemtuzumab over 5 Years (S51.003). Neurology. 86(16_supplement). 7 indexed citations
16.
Singer, B., Edward Fox, Stephen Krieger, et al.. (2015). Durable Efficacy of Alemtuzumab in Patients With Highly Active Relapsing-Remitting Multiple Sclerosis Who Relapsed on a Prior Therapy (P7.269). Neurology. 84(14_supplement). 1 indexed citations
17.
Kerns, Sarah L., Barry S. Rosenstein, Stephen Krieger, et al.. (2015). Lhermitte’s Sign following VMAT-Based Head and Neck Radiation-Insights into Mechanism. PLoS ONE. 10(10). e0139448–e0139448. 4 indexed citations
18.
Morsella, Ezequiel, et al.. (2015). Homing in on consciousness in the nervous system: An action-based synthesis. Behavioral and Brain Sciences. 39. e168–e168. 66 indexed citations
19.
Krieger, Stephen, Shawn F. Sorrells, Molly Nickerson, & Thaddeus W. W. Pace. (2014). Mechanistic insights into corticosteroids in multiple sclerosis: War horse or chameleon?☆. Clinical Neurology and Neurosurgery. 119. 6–16. 29 indexed citations
20.
Morsella, Ezequiel, Stephen Krieger, & John A. Bargh. (2009). Minimal neuroanatomy for a conscious brain: Homing in on the networks constituting consciousness. Neural Networks. 23(1). 14–15. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rosaria Sacco Breakdown of academic impact, for papers by Laura De Giglio Breakdown of academic impact, for papers by Giovanna Borriello Breakdown of academic impact, for papers by Aurélie Ruet Breakdown of academic impact, for papers by Alessandro d’Ambrosio Breakdown of academic impact, for papers by María José Sá Breakdown of academic impact, for papers by Rosa Gemma Viterbo Breakdown of academic impact, for papers by María Jesús Arévalo Breakdown of academic impact, for papers by Joseph Guarnaccia Breakdown of academic impact, for papers by Marta Radaelli
Rankless by CCL
2026